M. Haubitz et al., CHRONIC INDUCTION OF C-REACTIVE PROTEIN BY HEMODIALYSIS, BUT NOT BY PERITONEAL-DIALYSIS THERAPY, Peritoneal dialysis international, 16(2), 1996, pp. 158-162
Objective: Evaluation of the inflammatory activity in patients on chro
nic peritoneal dialysis (PD) and patients on chronic hemodialysis (HD)
in comparison to patients with chronic renal insufficiency without di
alysis treatment and healthy volunteers. Design: Open, nonrandomized p
rospective study. Setting: Nephrology Department, including HD and PD
therapy in a university hospital. Patients: Twenty-four patients on ch
ronic PD, 21 patients on chronic HD therapy using a cuprophan dialyzer
, 16 patients with chronic renal insufficiency without dialysis treatm
ent, and 33 healthy volunteers; 8 additional patients before and after
initiation of chronic HD therapy. All patients and controls were with
out infection or immunosuppressive therapy. Main Outcome Measures: As
a marker of the inflammatory activity in the different patient groups,
C-reactlve protein (CRP) was measured serially using a sensitive, enz
yme-linked, immunosorbent assay in order to detect values below the de
tection limit of standard assays. Results: All patient groups had CRP
levels higher than the normal controls (p < 0.01). Patients on HD had
CRP levels significantly higher than PD patients (p < 0.01) whose leve
ls were comparable to patients without dialysis therapy. Accordingly,
longitudinal measurements before and after initiation of chronic HD sh
owed a significant increase in CRP levels after the beginning of HD tr
eatment (p < 0.04). Conclusions: The results suggest that induction of
the inflammatory activity is lower during PD compared to HD, since st
imulation by the dialyzer membrane, dialysate buffer, or bacterial fra
gments in the dialysate is avoided. This observation might indicate a
possible lower risk of long-term complications in patients with PD.